Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 15/20 | 0.59 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.56 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.55 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | NPY1R | P25929 | 1/20 | 0.53 |
| ▸ | NPY2R | P49146 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6609768 | 0.91 | CYP1A2 (0.63) | CHRM3SOAT1CHRM2CHRM1ALDH1A1 | |
| SCHEMBL5475717 | 0.88 | PTPN1 (0.62) | CHRM3SOAT1CHRM2CHRM1L3MBTL1 | |
| SCHEMBL2070051 | 0.84 | CHRM3 (0.49) | CHRM3CHRM2CHRM1 | |
| SCHEMBL19713012 | 0.82 | CHRM3 (0.54) | CHRM3CHRM2CHRM1ALDH1A1NPY1R | |
| SCHEMBL2092774 | 0.80 | ALDH1A1 (0.57) | CHRM3SOAT1CHRM2CHRM1HTT | |
| SCHEMBL19713007 | 0.80 | CHRM3 (0.52) | CHRM3CHRM2CHRM1ALDH1A1NPY1R | |
| SCHEMBL17847445 | 0.80 | CHRM3 (0.55) | CHRM3CHRM2CHRM1ALDH1A1NPY1R | |
| SCHEMBL17847476 | 0.80 | CHRM3 (0.55) | CHRM3CHRM2CHRM1 | |
| SCHEMBL17847480 | 0.80 | CHRM3 (0.55) | CHRM3CHRM2CHRM1 | |
| SCHEMBL2070753 | 0.80 | SMN1; SMN2 (0.51) | CHRM3HTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9828339-B2 | Biphenyl derivatives and methods for preparing same | DONG-A ST CO., LTD (KR) | 2017-11-28 | — | — | US | disclosed |
| US-20160176816-A1 | NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME | DONG-A ST CO., LTD (KR) | 2016-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160176816-A1 | NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME | CHRM2, CHRM3, CHRM5 | CHRM3 2/4885SOAT1 1414/4885CHRM2 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.